Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Return on Sales (2016 - 2025)

Macrogenics (MGNX) has disclosed Return on Sales for 14 consecutive years, with 0.34% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 4.0% to 0.34% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.51% through Dec 2025, down 8.0% year-over-year, with the annual reading at 0.5% for FY2025, 5.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.34% at Macrogenics, down from 0.23% in the prior quarter.
  • The five-year high for Return on Sales was 0.51% in Q3 2024, with the low at 16.87% in Q2 2024.
  • Average Return on Sales over 5 years is 3.04%, with a median of 2.33% recorded in 2021.
  • The sharpest move saw Return on Sales plummeted -1339bps in 2024, then surged 1524bps in 2025.
  • Over 5 years, Return on Sales stood at 4.12% in 2021, then skyrocketed by 104bps to 0.16% in 2022, then tumbled by -2908bps to 4.6% in 2023, then soared by 92bps to 0.39% in 2024, then rose by 11bps to 0.34% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.34%, 0.23%, and 1.63% for Q4 2025, Q3 2025, and Q2 2025 respectively.